Table: begin end state 1 39 cytoplasmic 40 59 transmembrane 60 70 non-cytoplasmic 71 94 transmembrane 95 105 cytoplasmic 106 127 transmembrane 128 129 non-cytoplasmic 130 155 transmembrane 156 174 cytoplasmic 175 196 transmembrane 197 205 non-cytoplasmic 206 227 transmembrane 228 264 cytoplasmic 265 286 transmembrane 287 300 non-cytoplasmic 301 319 transmembrane 320 330 cytoplasmic 331 350 transmembrane 351 361 non-cytoplasmic 362 383 transmembrane 384 390 cytoplasmic 391 415 transmembrane 416 424 non-cytoplasmic 425 443 transmembrane 444 489 cytoplasmic
Input: >WP_011880619.1 NCBI__GCF_000016205.1:WP_011880619.1 MSSPHAHSAKTRSSRQALKLDDITIVDRAILKRAVGAMAFGNAMEWFDFGVYSYIAVTLG KVFFPSSSPSAQLLATFGTFAAAFVVRPLGGMVFGPLGDRIGRQRVLAATMIMMAVGTFA IGLIPSYASIGIMAPVLLLVARLVQGFSTGGEYGGAATFIAEFSTDKRRGFMGSFLEFGT LIGYTLGAATVTLLTATLSHDALLSWGWRVPFFIAGPLGLVGLYIRIKLEETPAFKKEAL AREADERARPKQSFGTLLVEQWRPLLQCVGLVLIFNVTDYMALSYLPNYLSATLHFNETH GLFMVLIVMLLMMPMTLYAGHLSDRIGRKPVMMFGCVGLLVLSVPALMLIRTGGMLPVFG GMLIYGTLLSTFTGVMPSALPALFPTRIRYGALAIGFNVSVSLFGGTTPLVTAWLVDRTG DLMMPAYYLMGASFIGIVSVLALRESARRPLPGSTPCVGSRAEAQELIRRGAGEVRGRER KLTPIGERA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server